Go Pro
→ A “bloodbath” Is Coming (From TradeSmith) (Ad)tc pixel Free TLSI Stock Alerts

TriSalus Life Sciences (TLSI) Short Interest Ratio & Short Volume

TriSalus Life Sciences logo
$4.83 -0.10 (-2.03%)
As of 08/28/2026 04:00 PM Eastern
Compare

TriSalus Life Sciences Short Interest Overview

As of August 14, 2026, TriSalus Life Sciences (TLSI) had a short interest of 3.79 million shares sold short, representing 7.36% of the public float. This marks a 0.47% increase in short interest since the prior report. The short interest ratio (days to cover) is 14.0, meaning it would take 14.0 days of the average trading volume of 196,601 shares to cover all short positions.

Current Short Interest
3,790,922 shares
Previous Short Interest
3,773,177 shares
Change Vs. Previous Month
0.47%
Dollar Volume Sold Short
$19.98 million
Short Interest Ratio
14.0 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
61,580,000 shares
Short Percent of Float
7.36%
Today's Trading Volume
79,974 shares
Average Trading Volume
196,601 shares
Today's Volume Vs. Average
41%
Short Selling TriSalus Life Sciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for TriSalus Life Sciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TLSI Short Interest Over Time

TLSI Days to Cover Over Time

TLSI Percentage of Float Shorted Over Time

TriSalus Life Sciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/20263,790,922 shares $19.98 million +0.5%7.4%14 $5.27
7/31/20263,773,177 shares $17.13 million +5.9%7.3%22.15 $4.54
7/15/20263,564,595 shares $14.61 million +15.7%6.9%12.88 $4.10
6/30/20263,080,231 shares $14.02 million +40.7%6.0%4.54 $4.55
6/15/20262,188,985 shares $9.19 million +4.2%4.3%6.76 $4.20
5/29/20262,101,834 shares $7.17 million +24.7%4.1%4.91 $3.41
5/15/20261,685,210 shares $4.52 million +16.8%3.3%1.65 $2.68
4/30/20261,442,308 shares $6.23 million +9.0%2.8%12.25 $4.32
4/15/20261,323,315 shares $5.94 million +10.5%2.6%8.84 $4.49
3/31/20261,198,022 shares $4.79 million +10.9%2.3%5.91 $4.00
3/13/20261,080,396 shares $4.41 million +9.5%2.1%4.35 $4.08
2/27/2026986,706 shares $4.99 million -15.0%1.9%4.14 $5.06
2/13/20261,160,400 shares $5.65 million +2.0%2.3%11.42 $4.87
1/30/20261,138,040 shares $5.66 million -9.4%2.2%8.33 $4.97
1/15/20261,255,516 shares $7.72 million -2.0%2.4%9.21 $6.15
12/31/20251,281,631 shares $8.95 million +61.3%2.5%5.3 $6.98
12/15/2025794,549 shares $5.81 million +5.3%1.5%4.39 $7.31
11/28/2025754,571 shares $5.14 million +18.4%1.5%4.7 $6.82
11/14/2025637,288 shares $2.91 million -0.8%1.8%6.06 $4.56
10/31/2025642,596 shares $3.05 million -12.0%1.8%6.08 $4.74
10/15/2025730,100 shares $3.31 million -20.5%4.5%6.1 $4.54
9/30/2025918,500 shares $4.27 million +78.2%5.7%9.1 $4.65
9/15/2025515,400 shares $2.37 million +12.8%3.2%4.2 $4.60
8/31/2025457,100 shares $2.39 million -17.3%2.8%4.4 $5.22
8/15/2025552,800 shares $2.52 million -5.2%3.4%5.6 $4.55
7/31/2025582,900 shares $2.47 million -3.7%3.9%7 $4.23
7/15/2025605,300 shares $2.87 million +10.0%3.8%8.2 $4.74
6/30/2025550,400 shares $3.00 million +359.8%3.5%7.3 $5.45
6/15/2025119,700 shares $621.24 thousand +266.1%0.8%2.5 $5.19
5/31/202532,700 shares $177.56 thousand -70.0%0.2%0.7 $5.43
5/15/2025109,000 shares $556.99 thousand +206.2%0.7%2.2 $5.11
4/30/202535,600 shares $182.63 thousand +34.9%0.3%0.7 $5.13
4/15/202526,400 shares $145.73 thousand -78.5%0.2%0.5 $5.52
3/31/2025123,000 shares $678.96 thousand -0.9%0.9%2.6 $5.52
3/15/2025124,100 shares $652.77 thousand -8.8%1.0%2.7 $5.26
2/28/2025136,100 shares $783.94 thousand +6.3%1.1%3.6 $5.76
2/15/2025128,000 shares $723.20 thousand +75.3%1.2%3.1 $5.65
1/31/202573,000 shares $373.03 thousand -12.2%0.7%1.8 $5.11
1/15/202583,100 shares $398.88 thousand -0.8%0.8%2.2 $4.80
12/31/202483,800 shares $419.84 thousand +45.5%2.4%2.2 $5.01
A $382 trillion migration and the position no one is talking about (Ad)

Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.' Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move.tc pixel

Click here to see the full research and the position name
12/15/202457,600 shares $225.22 thousand +22.8%1.7%1.6 $3.91
11/30/202446,900 shares $213.86 thousand +47.5%1.7%1.1 $4.56
11/15/202431,800 shares $124.97 thousand -45.6%0.7%0.7 $3.93
10/31/202458,400 shares $231.85 thousand -6.0%1.3%1.3 $3.97
10/15/202462,100 shares $276.97 thousand +21.3%1.4%1.3 $4.46
9/30/202451,200 shares $236.03 thousand +62.5%1.0%1.1 $4.61
9/15/202431,500 shares $142.38 thousand -4.3%0.6%0.7 $4.52
8/31/202432,900 shares $172.73 thousand -20.0%0.6%0.8 $5.25
8/15/202441,100 shares $242.08 thousand -4.2%0.8%1 $5.89
7/31/202442,900 shares $244.53 thousand -18.0%1.3%1.3 $5.70
7/15/202452,300 shares $272.48 thousand -88.5%1.6%1.3 $5.21
6/30/2024453,500 shares $2.50 million +7.5%13.9%10.7 $5.52
6/15/2024421,900 shares $2.43 million +2.1%13.6%9.4 $5.77
5/31/2024413,400 shares $2.96 million +140.2%15.1%8.5 $7.16
5/15/2024172,100 shares $1.62 million +1.5%6.3%3.8 $9.39
4/30/2024169,600 shares $1.58 million -38.6%7.1%4.3 $9.31
4/15/2024276,300 shares $2.62 million -3.9%11.7%9 $9.50
3/31/2024287,400 shares $2.80 million +12.8%12.3%9.1 $9.75
3/15/2024254,900 shares $2.48 million -0.2%10.9%7.1 $9.73
2/29/2024255,400 shares $2.44 million +1.0%11.0%3.7 $9.54
2/15/2024252,900 shares $2.42 million -5.6%10.9%3.7 $9.58
1/31/2024267,800 shares $2.42 million No Change10.4%3.6 $9.04

TLSI Short Interest - Frequently Asked Questions

Short interest is the volume of TriSalus Life Sciences shares that have been sold short but have not yet been covered or closed out. As of August 14th, traders have sold 3,790,922 shares of TLSI short. 7.36% of TriSalus Life Sciences' shares are currently sold short. Learn More on TriSalus Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLSI shares currently have a short interest ratio of 14.0. Learn More on TriSalus Life Sciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.36% of TriSalus Life Sciences' floating shares are currently sold short.

TriSalus Life Sciences saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 3,790,922 shares, an increase of 0.5% from the previous total of 3,773,177 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.36% of TriSalus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare equipment" compare to TriSalus Life Sciences: Alpha Tau Medical Ltd. (5.60%), PROCEPT BioRobotics Corporation (14.01%), STAAR Surgical Company (14.57%), Bioventus Inc. (4.17%), Anbio Biotechnology (0.02%), iRadimed Corporation (8.70%), CeriBell, Inc. (6.66%), Anteris Technologies Global Corp. (7.45%), Beta Bionics, Inc. (17.59%), SiBone (12.54%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling TLSI is an investing strategy that aims to generate trading profit from TriSalus Life Sciences as its price is falling. TLSI shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TriSalus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TLSI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLSI, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TLSI:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:TLSI is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...
Porter & Company | Sponsoredtc pixel
Now that SpaceX is public, buy this ticker (no, not SpaceX or Tesla)
The SpaceX IPO wasn't the big trade - according to Larry Benedict, founder of The Opportunistic Trader, it was...
Brownstone Research | Sponsoredtc pixel
SPDR Gold just lost $14 billion.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
Why the Treasury still prices gold at 42 dollars an ounce
The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...
Golden Portfolio | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel